NYSE:PHRHealthcare Services
A Look At Phreesia (PHR) Valuation After Fiscal 2027 Guidance Cut And Analyst Downgrades
Why Phreesia’s latest guidance cut matters for investors
Phreesia (PHR) has drawn fresh attention after issuing lower fiscal 2027 revenue guidance, tying the reset to weaker spending from pharmaceutical clients. The announcement triggered a sharp share price drop and several analyst downgrades.
See our latest analysis for Phreesia.
The lowered fiscal 2027 revenue outlook, combined with mixed fourth quarter results and analyst downgrades, has sharply shifted sentiment. A 7 day share price...